Metabolic and skeletal complications of HIV infection: the price of success
CG Morse, JA Kovacs - Jama, 2006 - jamanetwork.com
Over the past 10 years, in conjunction with the broad availability of potent antiretroviral
regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted
from prevention and treatment of opportunistic infections and malignancies to management
of the metabolic and related complications associated with HIV infection and its treatment.
Metabolic disorders, including lipodystrophy, dyslipidemia, and insulin resistance, occur at a
high rate in HIV-infected individuals receiving highly active antiretroviral therapy (HAART) …
regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted
from prevention and treatment of opportunistic infections and malignancies to management
of the metabolic and related complications associated with HIV infection and its treatment.
Metabolic disorders, including lipodystrophy, dyslipidemia, and insulin resistance, occur at a
high rate in HIV-infected individuals receiving highly active antiretroviral therapy (HAART) …